DOI: https://doi.org/10.22141/2224-0713.4.106.2019.174056
Spinal muscular atrophies in children: epidemiology, phenotypic features and modern opportunities of early clinical and instrumental diagnosis
Abstract
Keywords
Full Text:
PDF (Русский)References
Гузева В.И. и др. Детская неврология: Клинические рекомендации. М.: СИМК, 2015. 332 с.
Евтушенко С.К., Шаймурзин М.Р. Нейромышечные заболевания у детей: проблемы ранней диагностики и современной меди-цинской и социальной реабилитации (научный обзор и собственные наблюдения). Межд. невр. журн. 2013. Т. 5, № 59. С. 1333.
Евтушенко С.К. и др. Нейромышечные заболевания у детей. Донецк: Ноулидж, 2014. 218 с.
Петрухин А.С., Бобылова М.Ю. Детская неврология. М.: ГЭОТАРМедиа, 2018. Т. 2. 555 с.
Соколова М.Г. и др. Спинальная мышечная атрофия у детей: этиология, патогенез, диагностика и принципы лечения. Вест-ник СЗГМУ. 2013. Т. 5, № 4. С. 108114.
Яхно Н.Н., Парфенов В.А., Дамулин И.В. Нервные болезни. Общая неврология. М.: МИА, 2014. 256 с.
Arnold W.D. Spinal muscular atrophy: Diagnosis and management in a new therapeutic era. Muscle Nerve. 2015. Vol. 51, № 2. P. 15767.
Arnold E.S. Spinal muscular atrophy. Handb. Clin. Neurol. 2018. Vol. 148. P. 591601.
Carré A. Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors. J. Genet. Couns. 2016. Vol. 25, № 1. P. 3243.
De Sanctis R. [et al.]. Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy. Neuromuscular Disorders. 2018. Vol. 28. P. 2428.
Darras B.T. Spinal muscular atrophies. Pediatr. Clin. North Am. 2015. Vol. 62, № 3. P. 74366.
Finkel R.S. [et al.]. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul. Disord. 2018. Vol. 28, № 3. P. 197207.
GarcíaSalido A. [et al.]. Palliative care in children with spinal muscular atrophy type I: What do they need? Palliat Support Care. 2015. Vol. 13, № 2. P. 313316.
Mercuri E. [et al.]. Patterns of disease progression in type 2 and 3 SMA: Implications for clinical. Neuromuscular Disorders. 2016. Vol. 26, № 2. P. 126131.
Kraszewski J.N. [et al.]. Pilot study of populationbased newborn screening for spinal muscular atrophy in New York state. Genet. Med. 2018. Vol. 20, № 6. P. 608613.
Higashihara M. [et al.]. Quantitative Analysis of Surface Electromyography for Pediatric Neuromuscular Disorders. Muscle Nerve. 2018. Vol. 58, № 6. P. 824827.
Sampaio H., Wilcken B., Farrar M. Screening for spinal muscular atrophy. Med. J. Aust. 2018. Vol. 209, № 4. P. 147148.
Shababi M., Lorson C.L., RudnikSchöneborn S.S. Spinal muscular atrophy: a motor neuron disorder or a multiorgan disease? J. Anat. 2014. Vol. 224, № 1. P. 1528.
Vill K. [et al.]. Spinal muscular atrophy : Time for newborn screening? Nervenarzt. 2017. Vol. 88, № 12. P. 135866.
Copyright (c) 2019 INTERNATIONAL NEUROLOGICAL JOURNAL

This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2019
